Genetic aberrations at various levels of this pathway, including PI3K, AKT, TSC, and mTOR, have been identified within the context of TET.A gene mutation affecting the regulatory subunit of PI3K has been identified in a thymic carcinoma cell line. This evidence concerns the gene PIK3CG and thymic carcinoma.